Frantzi, M.; Hupe, M.C.; Merseburger, A.S.; Schanstra, J.P.; Mischak, H.; Latosinska, A.
Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer. Diagnostics 2020, 10, 658.
https://doi.org/10.3390/diagnostics10090658
AMA Style
Frantzi M, Hupe MC, Merseburger AS, Schanstra JP, Mischak H, Latosinska A.
Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer. Diagnostics. 2020; 10(9):658.
https://doi.org/10.3390/diagnostics10090658
Chicago/Turabian Style
Frantzi, Maria, Marie C. Hupe, Axel S. Merseburger, Joost P. Schanstra, Harald Mischak, and Agnieszka Latosinska.
2020. "Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer" Diagnostics 10, no. 9: 658.
https://doi.org/10.3390/diagnostics10090658
APA Style
Frantzi, M., Hupe, M. C., Merseburger, A. S., Schanstra, J. P., Mischak, H., & Latosinska, A.
(2020). Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer. Diagnostics, 10(9), 658.
https://doi.org/10.3390/diagnostics10090658